Insider Transactions in Q1 2021 at Stoneridge Inc (SRI)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 10
2021
|
Laurent Borne CTO and Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,598
-24.51%
|
$129,528
$36.46 P/Share
|
Mar 10
2021
|
Laurent Borne CTO and Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,166
+45.32%
|
-
|
Mar 09
2021
|
Paul J. Schlather Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+3.99%
|
-
|
Mar 09
2021
|
Kim Korth Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+4.7%
|
-
|
Mar 09
2021
|
Frank S Sklarsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+50.0%
|
-
|
Mar 09
2021
|
Douglas C Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+4.38%
|
-
|
Mar 09
2021
|
Jeffrey P Draime Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+3.11%
|
-
|
Mar 09
2021
|
George S Mayes Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+5.58%
|
-
|
Mar 09
2021
|
William M Lasky Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+2.34%
|
-
|
Mar 09
2021
|
Ira C. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,293
+24.58%
|
-
|
Mar 06
2021
|
Susan C. Benedict CHRO and Assistant GC |
BUY
Grant, award, or other acquisition
|
Direct |
682
+45.56%
|
-
|
Mar 06
2021
|
Susan C. Benedict CHRO and Assistant GC |
SELL
Payment of exercise price or tax liability
|
Direct |
417
-75.82%
|
$14,178
$34.7 P/Share
|
Mar 06
2021
|
Susan C. Benedict CHRO and Assistant GC |
BUY
Exercise of conversion of derivative security
|
Direct |
550
+50.0%
|
-
|
Mar 06
2021
|
Thomas Michael Dono Jr Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,374
-29.26%
|
$148,716
$34.7 P/Share
|
Mar 06
2021
|
Thomas Michael Dono Jr Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,239
+35.53%
|
-
|
Mar 06
2021
|
Thomas Michael Dono Jr Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,710
+50.0%
|
-
|
Mar 06
2021
|
Daniel M Kusiak Chief Procurement Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,757
-13.62%
|
$59,738
$34.7 P/Share
|
Mar 06
2021
|
Daniel M Kusiak Chief Procurement Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,127
+19.51%
|
-
|
Mar 06
2021
|
Daniel M Kusiak Chief Procurement Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,550
+20.7%
|
-
|
Mar 06
2021
|
Robert J. Hartman Jr. Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,357
-3.85%
|
$46,138
$34.7 P/Share
|
Mar 06
2021
|
Robert J. Hartman Jr. Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,354
+6.26%
|
-
|
Mar 06
2021
|
Robert J. Hartman Jr. Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,920
+5.52%
|
-
|
Mar 06
2021
|
Robert R. Krakowiak EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,355
-9.7%
|
$216,070
$34.7 P/Share
|
Mar 06
2021
|
Robert R. Krakowiak EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
12,101
+15.6%
|
-
|
Mar 06
2021
|
Robert R. Krakowiak EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,850
+15.58%
|
-
|
Mar 06
2021
|
Jonathan B De Gaynor President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,825
-13.25%
|
$946,050
$34.7 P/Share
|
Mar 06
2021
|
Jonathan B De Gaynor President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,662
+16.22%
|
-
|
Mar 06
2021
|
Jonathan B De Gaynor President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,100
+16.35%
|
-
|
Feb 16
2021
|
Jonathan B De Gaynor President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-6.84%
|
$290,000
$29.93 P/Share
|
Jan 20
2021
|
Jonathan B De Gaynor President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-6.4%
|
$300,000
$30.23 P/Share
|